These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 35605297)

  • 1. Pathological features-based targeted delivery strategies in IBD therapy: A mini review.
    Li S; Zhang F; Zhang Q
    Biomed Pharmacother; 2022 Jul; 151():113079. PubMed ID: 35605297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Site-specific targeted drug delivery systems for the treatment of inflammatory bowel disease.
    Li X; Lu C; Yang Y; Yu C; Rao Y
    Biomed Pharmacother; 2020 Sep; 129():110486. PubMed ID: 32768972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticle-Mediated Drug Delivery Systems For The Treatment Of IBD: Current Perspectives.
    Yang C; Merlin D
    Int J Nanomedicine; 2019; 14():8875-8889. PubMed ID: 32009785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanomedicine-mediated drug delivery for potential treatment of inflammatory bowel disease: a narrative review.
    Ardekani ZM; Lorenzo-Leal AL; Bach H
    Nanomedicine (Lond); 2024 Jan; 19(2):163-179. PubMed ID: 38284393
    [No Abstract]   [Full Text] [Related]  

  • 5. Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: selective targeting to diseased versus healthy tissue.
    Hua S; Marks E; Schneider JJ; Keely S
    Nanomedicine; 2015 Jul; 11(5):1117-32. PubMed ID: 25784453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanomedicine and drug delivery strategies for treatment of inflammatory bowel disease.
    Takedatsu H; Mitsuyama K; Torimura T
    World J Gastroenterol; 2015 Oct; 21(40):11343-52. PubMed ID: 26525603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical delivery of steroids in inflammatory bowel disease.
    Girlich C; Scholmerich J
    Curr Drug Deliv; 2012 Jul; 9(4):345-9. PubMed ID: 22762277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Polyphenols in the treatment of inflammatory bowel diseases].
    Chojnacka K; Laskowska J
    Postepy Biochem; 2020 Sep; 66(3):256-262. PubMed ID: 33315320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orally-administered nanomedicine systems targeting colon inflammation for the treatment of inflammatory bowel disease: latest advances.
    Hu S; Zhao R; Xu Y; Gu Z; Zhu B; Hu J
    J Mater Chem B; 2023 Dec; 12(1):13-38. PubMed ID: 38018424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of antibiotics in the treatment of inflammatory bowel disease.
    Perencevich M; Burakoff R
    Inflamm Bowel Dis; 2006 Jul; 12(7):651-64. PubMed ID: 16804403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of Saccharomyces boulardii as a treatment option in IBD.
    Sivananthan K; Petersen AM
    Immunopharmacol Immunotoxicol; 2018 Dec; 40(6):465-475. PubMed ID: 29771163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current Strategies and Potential Prospects of Nanomedicine-Mediated Therapy in Inflammatory Bowel Disease.
    Chen F; Liu Q; Xiong Y; Xu L
    Int J Nanomedicine; 2021; 16():4225-4237. PubMed ID: 34188471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of inflammatory bowel disease (IBD).
    Pithadia AB; Jain S
    Pharmacol Rep; 2011; 63(3):629-42. PubMed ID: 21857074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New therapies for inflammatory bowel disease: from the bench to the bedside.
    Danese S
    Gut; 2012 Jun; 61(6):918-32. PubMed ID: 22115827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colonic inflammatory bowel disease. Medical therapies for colonic Crohn's disease and ulcerative colitis.
    Tung JK; Warner AS
    Postgrad Med; 2002 Nov; 112(5):45-8, 51. PubMed ID: 12462184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential prospects of nanomedicine for targeted therapeutics in inflammatory bowel diseases.
    Pichai MV; Ferguson LR
    World J Gastroenterol; 2012 Jun; 18(23):2895-901. PubMed ID: 22736912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory Bowel Disease: Pathogenesis, Causative Factors, Issues, Drug Treatment Strategies, and Delivery Approaches.
    Singh D; Srivastava S; Pradhan M; Kanwar JR; Singh MR
    Crit Rev Ther Drug Carrier Syst; 2015; 32(3):181-214. PubMed ID: 26080808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phytochemicals and their potential usefulness in inflammatory bowel disease.
    Somani SJ; Modi KP; Majumdar AS; Sadarani BN
    Phytother Res; 2015 Mar; 29(3):339-50. PubMed ID: 25572840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biosimilars in inflammatory bowel disease.
    Talathi S; Baig KRKK
    J Dig Dis; 2020 Nov; 21(11):610-620. PubMed ID: 32920972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation-specific targeted carriers for local drug delivery to inflammatory bowel disease.
    Kotla NG; Singh R; Baby BV; Rasala S; Rasool J; Hynes SO; Martin D; Egan LJ; Vemula PK; Jala VR; Rochev Y; Pandit A
    Biomaterials; 2022 Feb; 281():121364. PubMed ID: 35066288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.